Literature DB >> 15770072

Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.

Akiko Soyama1, Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Kazuo Komamura, Shiro Kamakura, Masafumi Kitakaze, Hitonobu Tomoike, Kazuyuki Ueno, Yu-ichi Goto, Hideo Kimura, Masaaki Katoh, Kenji Sugai, Osamu Saitoh, Mitsuru Kawai, Teiichi Ohnuma, Taisuke Ohtsuki, Chieko Suzuki, Narihiro Minami, Naoyuki Kamatani, Shogo Ozawa, Jun-ichi Sawada.   

Abstract

In order to identify genetic polymorphisms and haplotype frequencies of CYP1A2 in a Japanese population, the enhancer and promoter regions, all the exons with their surrounding introns, and intron 1 were sequenced from genomic DNA from 250 Japanese subjects. Thirty-three polymorphisms were found, including 13 novel ones: 2 in the enhancer region, 5 in the exons, and 6 in the introns. The most common single nucleotide polymorphism (SNP) was -163C>A (CYP1A2*1F allele) with a 0.628 frequency. In addition to six previously reported non-synonymous SNPs, three novel ones, 125C>G (P42R, CYP1A2*15 allele, MPJ6_1A2032), 1130G>A (R377Q, *16 allele, MPJ6_1A2033), and 1367G>A (R456H, *8 allele, MPJ6_1A2019), were found with frequencies of 0.002, 0.002, and 0.004, respectively. No polymorphism was found in the known nuclear transcriptional factor-binding sites in the enhancer region. Based on linkage disequilibrium analysis, the CYP1A2 gene was analyzed as one haplotype block. Using the 33 detected polymorphisms, 14 haplotypes were unambiguously identified, and 17 haplotypes were inferred by aid of an expectation-maximization-based program. Among them, the second major haplotype CYP1A2*1L is composed of -3860G>A (*1C allele), -2467delT (*1D allele), and -163C>A (*1F allele). Network analysis suggested that relatively rare haplotypes were derived from three major haplotypes, *1A, *1M, and *1N in most cases. Our findings provide fundamental and useful information for genotyping CYP1A2 in the Japanese, and probably Asian populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770072     DOI: 10.2133/dmpk.20.24

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  13 in total

Review 1.  Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.

Authors:  Carsten Skarke; Anja Kirchhof; Gerd Geisslinger; Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2005-11-24       Impact factor: 2.953

2.  PharmGKB summary: very important pharmacogene information for CYP1A2.

Authors:  Caroline F Thorn; Eleni Aklillu; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-01       Impact factor: 2.089

3.  Polymorphisms of cytochrome p450 genes in three ethnic groups from Russia.

Authors:  Gülnaz Korytina; Olga Kochetova; Leysan Akhmadishina; Elena Viktorova; Tatyana Victorova
Journal:  Balkan Med J       Date:  2012-09-01       Impact factor: 2.021

4.  Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.

Authors:  Keiji Takata; Junji Saruwatari; Naoyuki Nakada; Mizuna Nakagawa; Koichiro Fukuda; Fujiho Tanaka; Shinobu Takenaka; Shuichi Mihara; Toru Marubayashi; Kazuko Nakagawa
Journal:  Eur J Clin Pharmacol       Date:  2005-12-30       Impact factor: 2.953

Review 5.  The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response.

Authors:  Em Sutrisna
Journal:  J Clin Diagn Res       Date:  2016-11-01

Review 6.  Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.

Authors:  Shu-Feng Zhou; Li-Ping Yang; Zhi-Wei Zhou; Ya-He Liu; Eli Chan
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

7.  Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes.

Authors:  Haifeng Zhang; Na Gao; Tingting Liu; Yan Fang; Bing Qi; Qiang Wen; Jun Zhou; Linjing Jia; Hailing Qiao
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

8.  Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.

Authors:  Jing Li; Xingzhen Lao; Chao Zhang; Lei Tian; Dongsheng Lu; Shuhua Xu
Journal:  BMC Genet       Date:  2014-05-01       Impact factor: 2.797

9.  Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q).

Authors:  Young-Ran Lim; In-Hyeok Kim; Songhee Han; Hyoung-Goo Park; Mi-Jung Ko; Young-Jin Chun; Chul-Ho Yun; Donghak Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-03-01       Impact factor: 4.634

10.  Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.

Authors:  Yongchao Ren; Fang Liu; Xugang Shi; Tingting Geng; Dongya Yuan; Li Wang; Longli Kang; Tianbo Jin; Chao Chen
Journal:  Mol Med Rep       Date:  2017-05-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.